[
    [
        {
            "time": "2020-03-22",
            "original_text": "财闻点金：上万亿投资资金提前落地 二季度经济有望大反弹",
            "features": {
                "keywords": [
                    "投资资金",
                    "提前落地",
                    "二季度",
                    "经济反弹"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "宏观经济"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "财闻点金：上万亿投资资金提前落地 二季度经济有望大反弹",
                "Correlation": 3,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-04-25",
            "original_text": "恒瑞医药2019年净利润增长逾三成",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "净利润",
                    "增长",
                    "三成"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药2019年净利润增长逾三成",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-03-22",
            "original_text": "恒瑞医药2019年度财务指标",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "财务指标",
                    "2019年度"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "恒瑞医药2019年度财务指标",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 4,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-03-22",
            "original_text": "恒瑞医药2019年度分配预案：拟10送2股派2.3元",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "分配预案",
                    "10送2股派2.3元"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药2019年度分配预案：拟10送2股派2.3元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-03-22",
            "original_text": "恒瑞医药2019年营收同比增长三成",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "营收",
                    "同比增长",
                    "三成"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药2019年营收同比增长三成",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-03-22",
            "original_text": "恒瑞医药2019年净利同比增长31% “职业经理人时代”更加注重国际化",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "净利",
                    "同比增长",
                    "31%",
                    "国际化"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药2019年净利同比增长31% “职业经理人时代”更加注重国际化",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-03-22",
            "original_text": "恒瑞医药2019年报：收入232.9亿，净利润53.3亿，双双高增长；销售、研发、国际化无短板！",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "年报",
                    "收入",
                    "净利润",
                    "高增长",
                    "研发",
                    "国际化"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药2019年报：收入232.9亿，净利润53.3亿，双双高增长；销售、研发、国际化无短板！",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 4,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-03-22",
            "original_text": "方正证券大股东债券危机破产重整 人保资产固收产品“跌停”疑似踩雷 减资破产",
            "features": {
                "keywords": [
                    "方正证券",
                    "债券危机",
                    "破产重整",
                    "人保资产",
                    "固收产品",
                    "跌停",
                    "踩雷"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "方正证券大股东债券危机破产重整 人保资产固收产品“跌停”疑似踩雷 减资破产",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]